GenVec, Inc. (NASDAQ:GNVC)

daviducsb (31.32) Submitted: 12/29/2006 2:13:48 PM : Start Price: $23.90 GNVC Score: -88.42

Looks undervalued

Nhymn (54.96) Submitted: 12/28/2006 5:56:19 PM : Start Price: $23.80 GNVC Score: -88.21

I wish I could say Iexpect this to outperform for years with their pancreatic cancer drug; at best it's a bad risk, but hey I like to step out on a limb once in a while. Ok a lot!

vittorio301 (70.73) Submitted: 12/20/2006 12:09:53 PM : Start Price: $21.69 GNVC Score: -86.86

I

obiwankenobe1250 (93.06) Submitted: 12/20/2006 6:48:51 AM : Start Price: $21.60 GNVC Score: -86.96

Good news on their drug for pancreatic cancer treatment. Fundamentals are not that hot; in fact, they're bad, however, the hype is very good!

southernair (< 20) Submitted: 12/19/2006 3:54:14 PM : Start Price: $25.80 GNVC Score: -89.15

They're involved with human trials (with Nat'l Institute of Health) with an HIV vaccine that's showing GREAT promise.

SeqWo (77.60) Submitted: 12/19/2006 3:41:36 PM : Start Price: $25.90 GNVC Score: -89.19

initial trials of a pancreatic cancer treatment were positive...

bunji (< 20) Submitted: 12/18/2006 1:16:45 PM : Start Price: $18.70 GNVC Score: -85.07

positive phase 1 trial for hiv drug